# Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-1-trial-of-the-safety-and-efficacy-of-fully-human-anti-bcma-car-t-cells-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jin Jie,Siguo Hao,Songfu Jiang,Zonghai Li,Min Yang,Wenhao Zhang,Kang Yu,Jun Xiao,Haitao Meng,Liyuan Ma,Mingxia He,Wei Wang,Xin Huang,Linjun Chen,Chongyun Xing,Daijing Yuan,Shasha Wang,Rong Tao,Lihui Dai,Hong Ma |
| Citations | 40 |
| DOI | 10.1182/blood-2019-126104 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3000223620 |
| Type | conference-abstract |
| Year | 2019 |

## Paper authors

- [Songfu Jiang](https://scholariq.org/researchers/songfu-jiang/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.